Luis F Porrata MD
Hematologic Oncology
Assistant Professor, Internal Medicine, Mayo Medical School
Dr. Porrata is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1996 - 2000
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1993 - 1996
- SUNY Upstate Medical UniversityClass of 1993
Certifications & Licensure
- MN State Medical License 1996 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma Start of enrollment: 2004 Oct 01
- Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Start of enrollment: 2007 Dec 01
Publications & Presentations
PubMed
- Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience.Steven R Hwang, Richard C Godby, Brianna J Negaard, Raphael Mwangi, Adrienne N Nedved
Blood Advances. 2025-02-25 - Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy.Aung M Tun, Yucai Wang, Seth Maliske, Ivana Micallef, David J Inwards
Transplantation and Cellular Therapy. 2024-10-01 - Day 100 Recovery of Absolute Number of Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cells Predicts Survival Post-Autologous Stem Cell Transplantation in Lymp...Luis F Porrata, Stephen M Ansell, Ivana N Micallef, Patrick B Johnston, Jose C Villasboas
Biomedicines. 2024-08-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: